|
|
News
CryoCath to present at 2006 RBC Capital Markets Health Care Conference
Montreal, December 7, 2006 - CryoCath Technologies Inc. (TSX: CYT), the global leader in cryotherapy products
to treat cardiovascular disease, today announced that Henri Vienneau, Interim
President and CEO of the Company, will present on the “Close to the Heart: New
Technology Solutions” panel at the 2006 RBC Capital Markets Health Care
Conference in New York on Wednesday, December 13, at 8:00a.m. EDT.
A
live audio webcast of CryoCath’s presentation will be available at www.cryocath.com. About CryoCath
CryoCath - www.cryocath.com - is a medical technology
company that leads the world in cryotherapy products to treat cardiovascular
disease. With a priority focus on providing physicians with a complete solution
of catheter and surgical products to treat cardiac arrhythmias, CryoCath has
multiple products approved in the U.S., across Europe and several ROW countries.
The Company is developing additional products to expand its pipeline of products
to treat cardiac arrhythmias.
For further information, please contact:
|
|
